# Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas

> **NCT04268121** · PHASE2 · RECRUITING · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group** · enrollment: 78 (estimated)

## Conditions studied

- Neuroendocrine Carcinoma
- Digestive Cancer

## Interventions

- **DRUG:** Neoadjuvant treatment
- **DRUG:** Adjuvant treatment

## Key facts

- **NCT ID:** NCT04268121
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-05
- **Primary completion:** 2027-01
- **Final completion:** 2031-01
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04268121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04268121, "Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04268121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*